Glenmede Trust’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $2.08M | Sell |
|
|||||
|
2024
Q4 | $1.98M | Sell |
|
|||||
|
2024
Q3 | $2.03M | Buy |
|
|||||
|
2024
Q2 | $1.57M | Buy |
|
|||||
|
2024
Q1 | $1.6M | Sell |
|
|||||
|
2023
Q4 | $1.69M | Buy |
|
|||||
|
2023
Q3 | $566K | Buy |
|
|||||
|
2023
Q2 | $469K | Hold |
|
|||||
|
2023
Q1 | $469K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $219K | Sell |
|
|||||
|
2022
Q2 | $122K | Sell |
|
|||||
|
2022
Q1 | $184K | Hold |
|
|||||
|
2021
Q4 | $150K | Hold |
|
|||||
|
2021
Q3 | $117K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $7K | Buy |
|
|||||
|
2020
Q2 | $3K | Buy |
|